![Jay L. Eastman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jay L. Eastman
Gründer bei EG Capital Group LLC
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Aaron J. Kowalski | M | - |
JDRF T1D Fund
![]() JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | 20 Jahre |
Doris Peterkin | F | - |
OncoPep, Inc.
![]() OncoPep, Inc. Investment ManagersFinance OncoPep, Inc. develops immunotherapeutics to prevent the progression of cancer, prolong survival, and restore the quality of life of patients. The company?s product, PVX-410, is a multi-peptide therapeutic cancer vaccine to target specific antigens found on the surface of multiple myeloma cancer cells. Its PVX-410 is targeted for smoldering multiple myeloma, a precursor disease. The company was founded by Doris Peterkin, Joslyn Dobson, and Marc A. Cohen in 2010 and is headquartered in North Andover, MA. | 14 Jahre |
Sean N. Doherty | M | 55 |
JDRF T1D Fund
![]() JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | 9 Jahre |
Clark Tim | M | - |
JDRF T1D Fund
![]() JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | 17 Jahre |
Sherr Jennifer | F | - |
JDRF T1D Fund
![]() JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | - |
Gerald L. Wisler | M | 67 |
JDRF T1D Fund
![]() JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | 7 Jahre |
John Mack | M | 79 |
Columbia University Medical Center
| - |
Francine Kaufman | M | 73 |
JDRF T1D Fund
![]() JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | - |
Buckingham Bruce | M | - |
JDRF T1D Fund
![]() JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | - |
Norm A. Gretzinger | M | - |
EG Capital Group LLC
![]() EG Capital Group LLC Investment ManagersFinance EG Capital Group LLC (EG Capital) is a private equity firm founded in 2003 by Jay L. Eastman and Norm A. Gretzinger. The firm is headquartered in New York. | 21 Jahre |
Joslyn Dobson | F | - |
OncoPep, Inc.
![]() OncoPep, Inc. Investment ManagersFinance OncoPep, Inc. develops immunotherapeutics to prevent the progression of cancer, prolong survival, and restore the quality of life of patients. The company?s product, PVX-410, is a multi-peptide therapeutic cancer vaccine to target specific antigens found on the surface of multiple myeloma cancer cells. Its PVX-410 is targeted for smoldering multiple myeloma, a precursor disease. The company was founded by Doris Peterkin, Joslyn Dobson, and Marc A. Cohen in 2010 and is headquartered in North Andover, MA. | 14 Jahre |
Dayan Colin | M | - |
JDRF T1D Fund
![]() JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | - |
Evans-Molina Carmella | F | - |
JDRF T1D Fund
![]() JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | - |
Douglas A. Melton | M | 70 |
JDRF T1D Fund
![]() JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | - |
Langer Robert | M | - |
JDRF T1D Fund
![]() JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | - |
Mathieu Chantal | F | - |
JDRF T1D Fund
![]() JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | - |
Gary K. Schwartz | M | - |
Columbia University Medical Center
| - |
Joseph Jurcic | M | - |
Columbia University Medical Center
| - |
Katie Ellias | F | 45 |
JDRF T1D Fund
![]() JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | 6 Jahre |
Victor Moyo | M | - |
OncoPep, Inc.
![]() OncoPep, Inc. Investment ManagersFinance OncoPep, Inc. develops immunotherapeutics to prevent the progression of cancer, prolong survival, and restore the quality of life of patients. The company?s product, PVX-410, is a multi-peptide therapeutic cancer vaccine to target specific antigens found on the surface of multiple myeloma cancer cells. Its PVX-410 is targeted for smoldering multiple myeloma, a precursor disease. The company was founded by Doris Peterkin, Joslyn Dobson, and Marc A. Cohen in 2010 and is headquartered in North Andover, MA. | 2 Jahre |
Jooeun Bae | M | - |
OncoPep, Inc.
![]() OncoPep, Inc. Investment ManagersFinance OncoPep, Inc. develops immunotherapeutics to prevent the progression of cancer, prolong survival, and restore the quality of life of patients. The company?s product, PVX-410, is a multi-peptide therapeutic cancer vaccine to target specific antigens found on the surface of multiple myeloma cancer cells. Its PVX-410 is targeted for smoldering multiple myeloma, a precursor disease. The company was founded by Doris Peterkin, Joslyn Dobson, and Marc A. Cohen in 2010 and is headquartered in North Andover, MA. | - |
Naseem Zojwalla | M | 51 |
Columbia University Medical Center
| - |
Michael Pitman | M | - |
Columbia University Medical Center
| - |
Joshua Sonett | M | - |
Columbia University Medical Center
| - |
Beth Schrope | F | - |
Columbia University Medical Center
| - |
David J. Lederer | M | - |
Columbia University Medical Center
| 16 Jahre |
Agiostratidou Gina | F | - |
JDRF T1D Fund
![]() JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | - |
Karen Jordan | F | - |
JDRF T1D Fund
![]() JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | - |
Nikhil C. Munshi | M | - |
OncoPep, Inc.
![]() OncoPep, Inc. Investment ManagersFinance OncoPep, Inc. develops immunotherapeutics to prevent the progression of cancer, prolong survival, and restore the quality of life of patients. The company?s product, PVX-410, is a multi-peptide therapeutic cancer vaccine to target specific antigens found on the surface of multiple myeloma cancer cells. Its PVX-410 is targeted for smoldering multiple myeloma, a precursor disease. The company was founded by Doris Peterkin, Joslyn Dobson, and Marc A. Cohen in 2010 and is headquartered in North Andover, MA. | - |
Grant Beard | M | 63 |
JDRF T1D Fund
![]() JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | 8 Jahre |
Darryl C. de Vivo | M | - |
Columbia University Medical Center
| - |
Dinakar Singh | M | 55 |
Columbia University Medical Center
| - |
Bruce Downey | M | 76 |
OncoPep, Inc.
![]() OncoPep, Inc. Investment ManagersFinance OncoPep, Inc. develops immunotherapeutics to prevent the progression of cancer, prolong survival, and restore the quality of life of patients. The company?s product, PVX-410, is a multi-peptide therapeutic cancer vaccine to target specific antigens found on the surface of multiple myeloma cancer cells. Its PVX-410 is targeted for smoldering multiple myeloma, a precursor disease. The company was founded by Doris Peterkin, Joslyn Dobson, and Marc A. Cohen in 2010 and is headquartered in North Andover, MA. | 13 Jahre |
Jonathan Leff | M | 55 |
Columbia University Medical Center
| - |
Michael Weiss | M | 73 |
Columbia University Medical Center
| 37 Jahre |
Noam Gottesman | M | 62 |
Columbia University Medical Center
| - |
Brady Bohrmann | M | - |
JDRF T1D Fund
![]() JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | 9 Jahre |
Paul B. Queally | M | 59 |
JDRF T1D Fund
![]() JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | - |
Elena Prokupets | M | 69 |
OncoPep, Inc.
![]() OncoPep, Inc. Investment ManagersFinance OncoPep, Inc. develops immunotherapeutics to prevent the progression of cancer, prolong survival, and restore the quality of life of patients. The company?s product, PVX-410, is a multi-peptide therapeutic cancer vaccine to target specific antigens found on the surface of multiple myeloma cancer cells. Its PVX-410 is targeted for smoldering multiple myeloma, a precursor disease. The company was founded by Doris Peterkin, Joslyn Dobson, and Marc A. Cohen in 2010 and is headquartered in North Andover, MA. | - |
Steven St. Peter | M | 57 |
JDRF T1D Fund
![]() JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | 5 Jahre |
Silviu Itescu | M | 67 |
Columbia University Medical Center
| - |
Stephan Anthony Mayer | M | - |
Columbia University Medical Center
| - |
Richard L. Berkowitz | M | - |
Columbia University Medical Center
| - |
Martin Leon | M | - |
Columbia University Medical Center
| 14 Jahre |
Stephen L. Newman | M | 73 |
JDRF T1D Fund
![]() JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | - |
David Ho | M | 71 |
Columbia University Medical Center
| - |
Kenneth Anderson | M | 72 |
OncoPep, Inc.
![]() OncoPep, Inc. Investment ManagersFinance OncoPep, Inc. develops immunotherapeutics to prevent the progression of cancer, prolong survival, and restore the quality of life of patients. The company?s product, PVX-410, is a multi-peptide therapeutic cancer vaccine to target specific antigens found on the surface of multiple myeloma cancer cells. Its PVX-410 is targeted for smoldering multiple myeloma, a precursor disease. The company was founded by Doris Peterkin, Joslyn Dobson, and Marc A. Cohen in 2010 and is headquartered in North Andover, MA. | 14 Jahre |
Andrew R. Marks | M | - |
Columbia University Medical Center
| - |
Ellen Leake | F | - |
JDRF T1D Fund
![]() JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | 4 Jahre |
Claudia A. Chiriboga | F | - |
Columbia University Medical Center
| - |
Peter John Sacripanti | M | 68 |
Columbia University Medical Center
| - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 51 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Jay L. Eastman
- Persönliches Netzwerk